Group 1 - Multiple newly established active equity funds have begun building positions, indicating that fund managers are actively entering the market [1][2] - Several funds have announced early closure of their fundraising periods, suggesting that managers aim to seize favorable entry points in the current market [1][4] - The recent performance of innovative pharmaceutical sectors has led to significant gains for funds heavily invested in this area [2][3] Group 2 - The A-share market is expected to maintain an upward trend, supported by a recovery in corporate performance and external factors becoming less disruptive [5][6] - Key sectors to watch include artificial intelligence, high-end manufacturing, and biomedicine, which are showing signs of progress and improvement [6] - The overall sentiment towards the mid-term market outlook remains optimistic, with a focus on structural opportunities and potential outperformers in traditional and new consumer sectors [6]

Group 1 - Multiple newly established active equity funds have begun building positions, indicating that fund managers are actively entering the market shortly after fund establishment [1][2] - The first fundraising scale of the newly established fund "Shenwan Lingshin Industry Selection" was 1.219 billion yuan, making it one of the few active equity products this year to exceed 1 billion yuan in fundraising [2] - The net value of "Shenwan Lingshin Industry Selection A" fluctuated from 0.9802 yuan on June 6 to 0.9885 yuan on June 13, reflecting active market engagement by the fund manager [2] Group 2 - Several funds have announced early closure of fundraising, such as "Zhaoshang Value Select Mixed Fund," which closed fundraising on June 25 instead of the originally planned July 4 [3][4] - The trend of early fundraising closures is becoming more common, with some funds having fundraising periods as short as two days, indicating a strategic move by fund managers to capitalize on current market opportunities [4] - Fund managers are optimistic about the A-share market's upward trend, citing external disturbances easing and a potential rebound in previously affected sectors like technology and overseas industries [5] Group 3 - The long-term outlook for the Chinese economy remains positive, with ongoing industrial development and improvements in corporate performance, particularly in sectors like artificial intelligence, high-end manufacturing, and biomedicine [5][6] - The overall sentiment towards the mid-term market trajectory is optimistic, with signs of recovery in free cash flow among all A-share listed companies [5] - Key areas of focus for investment include stable assets represented by banks, offensive upstream assets like gold and oil, and event-driven assets such as new consumer products [6]